Q4 2017 13F Holders as of 12/31/2017
-
Type / Class
-
Equity / COM
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
396K
-
Shares change
-
-670K
-
Total reported value, excl. options
-
$861K
-
Value change
-
-$1.43M
-
Number of buys
-
5
-
Number of sells
-
-6
-
Price
-
$2.18
Significant Holders of ProPhase Labs, Inc. - COM (PRPH) as of Q4 2017
13 filings reported holding PRPH - ProPhase Labs, Inc. - COM as of Q4 2017.
ProPhase Labs, Inc. - COM (PRPH) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 396K shares
.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (165K shares), Bank of New York Mellon Corp (118K shares), PNC FINANCIAL SERVICES GROUP, INC. (25.4K shares), DEUTSCHE BANK AG\ (18.6K shares), UBS Group AG (17.1K shares), NORTHERN TRUST CORP (15.1K shares), ACADIAN ASSET MANAGEMENT LLC (13.8K shares), CITADEL ADVISORS LLC (11.8K shares), COMMONWEALTH EQUITY SERVICES, LLC. (10K shares), and MORGAN STANLEY (850 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.